ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2026
Cochlear implant surgery using the 4 K-three-dimensional exoscope ORBEYE: a comparative study with conventional operative microscope.
Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Improved usability of an active-polarized 3D display in exoscopic surgery under non-optimal viewing conditions.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026Article
- Letter to the editor "Cochlear implant surgery using the 4 K-three-dimensional exoscope ORBEYE: a comparative study with conventional operative microscope".European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026Article
Corrections and comments
- Commented on by
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate the feasibility of the 4 K-three-dimensional (3D) exoscope ORBEYE (ExS) in cochlear implant (CI) surgery and compare its advantages and limitations with the conventional operating microscope (OM).
methodsWe retrospectively analyzed 77 consecutive CI surgeries performed between January 2019 and December 2023 (42 with ExS and 35 with OM). Surgical outcomes, complications, and hearing results were compared between the groups. Eight otologists completed a questionnaire comparing technical performance, operative performance, team interaction, and procedure-specific performance of both visualization systems.
resultsAll ExS group surgeries were successfully completed using the ExS alone. The operating time was significantly longer in the ExS group than in the OM group (162 vs. 130 min, p = 0.0051), and the resident participation rate in mastoidectomy procedures was higher (28.6% vs. 8.6%, p = 0.0417). When excluding cases where residents performed mastoidectomy, the operating time did not markedly differ between the groups (152 vs. 130.5 min, p = 0.1532). The hospital stay and complication rates were also comparable. Both systems achieved similar hearing improvements. The questionnaire results revealed a clear preference for ExS across all evaluation domains except for natural stereoscopic perception. ExS demonstrated advantages in implant bed creation, cochleostomy, and electrode insertion.
conclusionsThe 4 K-3D ExS ORBEYE demonstrated comparable surgical outcomes to those of conventional OM in CI surgery. The longer operative time in the ExS group appeared to reflect educational benefits rather than technical limitations. ExS offers a viable alternative to OM for CI surgery, with advantages across multiple performance domains, including team interaction and surgical education.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.